Verified investment lower bound≥$15.87M
Investment cases2
Manager operating history—
Representative investments
Individual transactions and cumulative snapshots use different bases. Do not add these rows again to cumulative totals.
| Date | Company | Round | Original-currency amount | Paying entity | Specific funds | Sources |
|---|---|---|---|---|---|---|
| 2026-01-09 | MiniMax | IPO基石获配 | HKD 77.8M | E Fund Management | — | Sources · 1
Basis and notes最终获配471,540股 × 165港元/股；计算值，不含佣金、征费及超额配售。仅本次IPO认购，非该机构全部历史投入；最终配发结果并非逐笔银行到账证明。 |
| 2025-12-30 | Insilico Medicine（英矽智能） | IPO最终获配认购 | HKD 31.12M | E Fund Management | E Fund Global Healthcare Sector Sponsored Hybrid Fund (QDII) | Sources · 2
Basis and notes基石获配1,294,000股×HK$24.05；招股书明确E Fund Global Healthcare Sector Sponsored Hybrid Fund (QDII)。额外645,000股单列，基金未披露不自动归入。IPO认购计算值，不含费用。 |
| 2025-12-30 | Insilico Medicine（英矽智能） | IPO最终获配认购 | HKD 15.51M | E Fund Management | — | Sources · 2
Basis and notes额外国际配售645,000股×HK$24.05；文件只列E Fund Management，具体法律基金未披露，未归入基石协议所列基金。与基石1,294,000股不重复。IPO获配认购计算值，非银行流水证明。 |